Trader consensus on Polymarket assigns an 88.5% implied probability to no new pandemic in 2026, driven by the absence of any novel pathogen achieving sustained human-to-human transmission at a global scale, as monitored by WHO and CDC surveillance networks. With over one-quarter of the year elapsed as of mid-April 2026, no outbreaks—such as regional Marburg cases in Africa or emerging H5N1 avian influenza detections—have escalated to pandemic thresholds under WHO's International Health Regulations, including the new "pandemic emergency" designation. Recent developments, including the COVID-19 BA.3.2 "Cicada" variant spreading in 23+ countries since late 2025, represent ongoing SARS-CoV-2 evolution rather than a distinct pathogen. Strengthened genomic surveillance in 110 countries and historical rarity of pandemics underpin this positioning, though experts continue tracking influenza D, mpox, and oropouche virus for spillover risks; key updates expected from WHO's weekly epidemiological reports.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$232,234 ปริมาณ
$232,234 ปริมาณ
$232,234 ปริมาณ
$232,234 ปริมาณ
The resolution source will be official announcements from the World Health Organization.
ตลาดเปิดเมื่อ: Dec 1, 2025, 4:37 PM ET
Resolver
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Resolver
0x65070BE91...Trader consensus on Polymarket assigns an 88.5% implied probability to no new pandemic in 2026, driven by the absence of any novel pathogen achieving sustained human-to-human transmission at a global scale, as monitored by WHO and CDC surveillance networks. With over one-quarter of the year elapsed as of mid-April 2026, no outbreaks—such as regional Marburg cases in Africa or emerging H5N1 avian influenza detections—have escalated to pandemic thresholds under WHO's International Health Regulations, including the new "pandemic emergency" designation. Recent developments, including the COVID-19 BA.3.2 "Cicada" variant spreading in 23+ countries since late 2025, represent ongoing SARS-CoV-2 evolution rather than a distinct pathogen. Strengthened genomic surveillance in 110 countries and historical rarity of pandemics underpin this positioning, though experts continue tracking influenza D, mpox, and oropouche virus for spillover risks; key updates expected from WHO's weekly epidemiological reports.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย